Oligometastatic Adenocarcinoma of the Lung: A Therapeutic Opportunity for Long-Term Survival

We report a case of oligometastatic non-small-cell lung cancer (NSCLC) in a 60-year-old male that was treated with both local and systemic therapies with an exceptional response to therapy. This case provides evidence that oligometastatic lung cancer, when treated with curative intent, may be an opp...

Descripción completa

Detalles Bibliográficos
Autores principales: Yarchoan, Mark, Lim, Michael, Brahmer, Julie R, Ettinger, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2015
Materias:
Radiation Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4725613/
https://www.ncbi.nlm.nih.gov/pubmed/26824009
http://dx.doi.org/10.7759/cureus.409
_version_ 1782411654235947008
author Yarchoan, Mark
Lim, Michael
Brahmer, Julie R
Ettinger, David
author_facet Yarchoan, Mark
Lim, Michael
Brahmer, Julie R
Ettinger, David
author_sort Yarchoan, Mark
collection PubMed
description We report a case of oligometastatic non-small-cell lung cancer (NSCLC) in a 60-year-old male that was treated with both local and systemic therapies with an exceptional response to therapy. This case provides evidence that oligometastatic lung cancer, when treated with curative intent, may be an opportunity for long-term survival in select patients.
format Online
Article
Text
id pubmed-4725613
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-47256132016-01-28 Oligometastatic Adenocarcinoma of the Lung: A Therapeutic Opportunity for Long-Term Survival Yarchoan, Mark Lim, Michael Brahmer, Julie R Ettinger, David Cureus Radiation Oncology We report a case of oligometastatic non-small-cell lung cancer (NSCLC) in a 60-year-old male that was treated with both local and systemic therapies with an exceptional response to therapy. This case provides evidence that oligometastatic lung cancer, when treated with curative intent, may be an opportunity for long-term survival in select patients. Cureus 2015-12-16 /pmc/articles/PMC4725613/ /pubmed/26824009 http://dx.doi.org/10.7759/cureus.409 Text en Copyright © 2015, Yarchoan et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Radiation Oncology
Yarchoan, Mark
Lim, Michael
Brahmer, Julie R
Ettinger, David
Oligometastatic Adenocarcinoma of the Lung: A Therapeutic Opportunity for Long-Term Survival
title Oligometastatic Adenocarcinoma of the Lung: A Therapeutic Opportunity for Long-Term Survival
title_full Oligometastatic Adenocarcinoma of the Lung: A Therapeutic Opportunity for Long-Term Survival
title_fullStr Oligometastatic Adenocarcinoma of the Lung: A Therapeutic Opportunity for Long-Term Survival
title_full_unstemmed Oligometastatic Adenocarcinoma of the Lung: A Therapeutic Opportunity for Long-Term Survival
title_short Oligometastatic Adenocarcinoma of the Lung: A Therapeutic Opportunity for Long-Term Survival
title_sort oligometastatic adenocarcinoma of the lung: a therapeutic opportunity for long-term survival
topic Radiation Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4725613/
https://www.ncbi.nlm.nih.gov/pubmed/26824009
http://dx.doi.org/10.7759/cureus.409
work_keys_str_mv AT yarchoanmark oligometastaticadenocarcinomaofthelungatherapeuticopportunityforlongtermsurvival
AT limmichael oligometastaticadenocarcinomaofthelungatherapeuticopportunityforlongtermsurvival
AT brahmerjulier oligometastaticadenocarcinomaofthelungatherapeuticopportunityforlongtermsurvival
AT ettingerdavid oligometastaticadenocarcinomaofthelungatherapeuticopportunityforlongtermsurvival

Ejemplares similares